ANTICUERPOS DIRIGIDOS CONTRA IL-22RA Y COMPAÑEROS DE UNION PROCEDIMIENTOS DE USO EN ENEFERMEDADES INFLAMATORIAS
Un anticuerpo o fragmento de unión a antígeno del mismo que se expresa mediante un hibridoma procedente del grupo de: (a) el clon de hibridoma 280.46.3.4 (Designación de depósito de patente ATCC PTA-6284); (b) el clon de hibridoma 281.73.49.1.1 (Designación de depósito de patente ATCC PTA-6285); (c)...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | XU, WENFENG LEHNER, JOYCE, M DILLON, STACEY, R CHANDRASEKHER, YASMIN, A KINDSVOGEL, WAYNE, R SIADAK, ANTHONY, W |
| description | Un anticuerpo o fragmento de unión a antígeno del mismo que se expresa mediante un hibridoma procedente del grupo de: (a) el clon de hibridoma 280.46.3.4 (Designación de depósito de patente ATCC PTA-6284); (b) el clon de hibridoma 281.73.49.1.1 (Designación de depósito de patente ATCC PTA-6285); (c) el clon de hibridoma 283.4.1.2 (Designación de depósito de patente ATCC PTA-6287); (d) el clon de hibridoma 283.52.5.4 (Designación de depósito de patente ATCC PTA-6311); y (e) el clon de hibridoma 283.108.2.3 (Designación de depósito de patente ATCC PTA-6286).
The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-22, IL-20, or both IL-20 and IL-22 polypeptide molecules. IL-20 and IL-22 are cytokines that are involved in inflammatory processes and human disease. IL-22RA (zcytor11) is a common receptor for IL-20 and IL-22. The present invention includes anti-IL-22RA antibodies and binding partners, as well as methods for antagonizing IL-22 or both IL-20 and IL-22 using such antibodies and binding partners. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2347672TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2347672TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2347672TT33</originalsourceid><addsrcrecordid>eNqNikEKwjAQRbtxIeod4gG6ScWuh2SqA01SJtOFq1IkrkQL9SKeyYsZoQcQPrzP462LCbyQ6ZG7EJUlphPZ_EzwwqCoLbXOvGThOvi8kX8Zqt5T8KrjYNCSI_Sy-BgU-jxskB1asBgV-aYFBxKYIG6L1W28z2m3cFPsGxRzLtP0HNI8jdf0SK8Bo64O9bHWIlX1T_MFRsk49A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTICUERPOS DIRIGIDOS CONTRA IL-22RA Y COMPAÑEROS DE UNION PROCEDIMIENTOS DE USO EN ENEFERMEDADES INFLAMATORIAS</title><source>esp@cenet</source><creator>XU, WENFENG ; LEHNER, JOYCE, M ; DILLON, STACEY, R ; CHANDRASEKHER, YASMIN, A ; KINDSVOGEL, WAYNE, R ; SIADAK, ANTHONY, W</creator><creatorcontrib>XU, WENFENG ; LEHNER, JOYCE, M ; DILLON, STACEY, R ; CHANDRASEKHER, YASMIN, A ; KINDSVOGEL, WAYNE, R ; SIADAK, ANTHONY, W</creatorcontrib><description>Un anticuerpo o fragmento de unión a antígeno del mismo que se expresa mediante un hibridoma procedente del grupo de: (a) el clon de hibridoma 280.46.3.4 (Designación de depósito de patente ATCC PTA-6284); (b) el clon de hibridoma 281.73.49.1.1 (Designación de depósito de patente ATCC PTA-6285); (c) el clon de hibridoma 283.4.1.2 (Designación de depósito de patente ATCC PTA-6287); (d) el clon de hibridoma 283.52.5.4 (Designación de depósito de patente ATCC PTA-6311); y (e) el clon de hibridoma 283.108.2.3 (Designación de depósito de patente ATCC PTA-6286).
The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-22, IL-20, or both IL-20 and IL-22 polypeptide molecules. IL-20 and IL-22 are cytokines that are involved in inflammatory processes and human disease. IL-22RA (zcytor11) is a common receptor for IL-20 and IL-22. The present invention includes anti-IL-22RA antibodies and binding partners, as well as methods for antagonizing IL-22 or both IL-20 and IL-22 using such antibodies and binding partners.</description><language>spa</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101103&DB=EPODOC&CC=ES&NR=2347672T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20101103&DB=EPODOC&CC=ES&NR=2347672T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>XU, WENFENG</creatorcontrib><creatorcontrib>LEHNER, JOYCE, M</creatorcontrib><creatorcontrib>DILLON, STACEY, R</creatorcontrib><creatorcontrib>CHANDRASEKHER, YASMIN, A</creatorcontrib><creatorcontrib>KINDSVOGEL, WAYNE, R</creatorcontrib><creatorcontrib>SIADAK, ANTHONY, W</creatorcontrib><title>ANTICUERPOS DIRIGIDOS CONTRA IL-22RA Y COMPAÑEROS DE UNION PROCEDIMIENTOS DE USO EN ENEFERMEDADES INFLAMATORIAS</title><description>Un anticuerpo o fragmento de unión a antígeno del mismo que se expresa mediante un hibridoma procedente del grupo de: (a) el clon de hibridoma 280.46.3.4 (Designación de depósito de patente ATCC PTA-6284); (b) el clon de hibridoma 281.73.49.1.1 (Designación de depósito de patente ATCC PTA-6285); (c) el clon de hibridoma 283.4.1.2 (Designación de depósito de patente ATCC PTA-6287); (d) el clon de hibridoma 283.52.5.4 (Designación de depósito de patente ATCC PTA-6311); y (e) el clon de hibridoma 283.108.2.3 (Designación de depósito de patente ATCC PTA-6286).
The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-22, IL-20, or both IL-20 and IL-22 polypeptide molecules. IL-20 and IL-22 are cytokines that are involved in inflammatory processes and human disease. IL-22RA (zcytor11) is a common receptor for IL-20 and IL-22. The present invention includes anti-IL-22RA antibodies and binding partners, as well as methods for antagonizing IL-22 or both IL-20 and IL-22 using such antibodies and binding partners.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNikEKwjAQRbtxIeod4gG6ScWuh2SqA01SJtOFq1IkrkQL9SKeyYsZoQcQPrzP462LCbyQ6ZG7EJUlphPZ_EzwwqCoLbXOvGThOvi8kX8Zqt5T8KrjYNCSI_Sy-BgU-jxskB1asBgV-aYFBxKYIG6L1W28z2m3cFPsGxRzLtP0HNI8jdf0SK8Bo64O9bHWIlX1T_MFRsk49A</recordid><startdate>20101103</startdate><enddate>20101103</enddate><creator>XU, WENFENG</creator><creator>LEHNER, JOYCE, M</creator><creator>DILLON, STACEY, R</creator><creator>CHANDRASEKHER, YASMIN, A</creator><creator>KINDSVOGEL, WAYNE, R</creator><creator>SIADAK, ANTHONY, W</creator><scope>EVB</scope></search><sort><creationdate>20101103</creationdate><title>ANTICUERPOS DIRIGIDOS CONTRA IL-22RA Y COMPAÑEROS DE UNION PROCEDIMIENTOS DE USO EN ENEFERMEDADES INFLAMATORIAS</title><author>XU, WENFENG ; LEHNER, JOYCE, M ; DILLON, STACEY, R ; CHANDRASEKHER, YASMIN, A ; KINDSVOGEL, WAYNE, R ; SIADAK, ANTHONY, W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2347672TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2010</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>XU, WENFENG</creatorcontrib><creatorcontrib>LEHNER, JOYCE, M</creatorcontrib><creatorcontrib>DILLON, STACEY, R</creatorcontrib><creatorcontrib>CHANDRASEKHER, YASMIN, A</creatorcontrib><creatorcontrib>KINDSVOGEL, WAYNE, R</creatorcontrib><creatorcontrib>SIADAK, ANTHONY, W</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>XU, WENFENG</au><au>LEHNER, JOYCE, M</au><au>DILLON, STACEY, R</au><au>CHANDRASEKHER, YASMIN, A</au><au>KINDSVOGEL, WAYNE, R</au><au>SIADAK, ANTHONY, W</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTICUERPOS DIRIGIDOS CONTRA IL-22RA Y COMPAÑEROS DE UNION PROCEDIMIENTOS DE USO EN ENEFERMEDADES INFLAMATORIAS</title><date>2010-11-03</date><risdate>2010</risdate><abstract>Un anticuerpo o fragmento de unión a antígeno del mismo que se expresa mediante un hibridoma procedente del grupo de: (a) el clon de hibridoma 280.46.3.4 (Designación de depósito de patente ATCC PTA-6284); (b) el clon de hibridoma 281.73.49.1.1 (Designación de depósito de patente ATCC PTA-6285); (c) el clon de hibridoma 283.4.1.2 (Designación de depósito de patente ATCC PTA-6287); (d) el clon de hibridoma 283.52.5.4 (Designación de depósito de patente ATCC PTA-6311); y (e) el clon de hibridoma 283.108.2.3 (Designación de depósito de patente ATCC PTA-6286).
The present invention relates to blocking, inhibiting, reducing, antagonizing or neutralizing the activity of IL-22, IL-20, or both IL-20 and IL-22 polypeptide molecules. IL-20 and IL-22 are cytokines that are involved in inflammatory processes and human disease. IL-22RA (zcytor11) is a common receptor for IL-20 and IL-22. The present invention includes anti-IL-22RA antibodies and binding partners, as well as methods for antagonizing IL-22 or both IL-20 and IL-22 using such antibodies and binding partners.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2347672TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY PEPTIDES |
| title | ANTICUERPOS DIRIGIDOS CONTRA IL-22RA Y COMPAÑEROS DE UNION PROCEDIMIENTOS DE USO EN ENEFERMEDADES INFLAMATORIAS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T12%3A33%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=XU,%20WENFENG&rft.date=2010-11-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2347672TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |